Log In
BCIQ
Print this Print this
 

AV-380

  Manage Alerts
Collapse Summary General Information
Company Aveo Pharmaceuticals Inc.
DescriptionAntibody against growth differentiation factor 15 (GDF15)
Molecular Target Growth differentiation factor 15 (GDF15)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationCachexia
Indication DetailsTreat cachexia
Regulatory Designation
PartnerNovartis AG

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$326.5M

$15.0M

$308.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/17/2015

$326.5M

$15.0M

$308.0M

Get a free BioCentury trial today